“Sunday Housecall” with Dr. Samadi, Renowned Doctor and Specialist in Prostate Cancer and Urology, Will Air Sundays on Fox News

As of September, Fox News Channel added a new live broadcast addressing various health issues. The host of the show is Dr. David Samadi, Chairman of Urology and Cheif of Robotic Surgery at Lenox Hill Hospital in New York City. Dr. Samadi’s new show, called “Sunday Housecall”, will air live on Sundays at 12:30 PM ET. Viewers will also be available to stream the show on YouTube Live, Facebook, or DrSamadiTV.com.

During the show, Dr. Samadi will be addressing health topics such as exercise, food and diet, common diseases, prostate health, sexual health, and other popular subjects. Since the show will be broadcasting live, viewers will be able to call in during the show to have some of their questions answered by Dr. Samadi himself or a health specialist. Guests, such as health specialists who have peer reviewed medical products, authors of books on health topics, or other experts in health and wellness, will be welcome on the show.

Regular viewers of Fox News Channel may recognize Dr. Samadi. He often contributes to the Fox News Health segment. One of the topics he recently addressed on the health segment is how adding plant protein to your diet can reduce the risk of death even if you don’t change other unhealthy lifestyle choices. Dr. Samadi encourages people to add more grains, vegetables, and other plants to their diet.

More About Dr. David Samadi

Dr. Samadi was born in Iran and fled the country with his brother due to the devastation of the Iranian Revolution. When Dr. Samadi applied for college, he received many scholarships for his major attempts to succeed after fleeing Iran. He earned his bachelor’s degree in biochemistry from Stony Brook University and continued at the Stony Brook School of Medicine to earn his medical degree. He graduated from medical school in 1994 and completed his residency at Montefiore Medical Center.

Dr. Samadi is well known for his tremendous success in urology. He earned the reputation of being one of the best cancer treatment specialists in the area. His specialties include treating bladder, kidney, and prostate cancer. He has helped many of his patients by finding innovative ways to treat their cancer. He hopes to bring global awareness to prostate cancer, the second leading cause of death in men.

Learn More:insider.foxnews.com/tag/dr-david-samadi

The Best of Clay Siegall

Clay Siegall is a prosperous individual who has achieved so much in life. He is also a philanthropist who has changed the lives of many and the society at large. Clay Siegall is the CEO and co-founder and also president of Seattle Genetic. In his education life he achieved a B.S in Zoology from the University of Maryland and a Ph.D from George Washington University in genetics. He also serves as a board member at the same company.

Clay Siegall is a well-known entrepreneur and scientist. Due to his hard work, Siegall received an award of the Alumnus of 2013 in natural sciences, computer and math from Maryland University. When it comes to science he is mostly focused on biotechnology.

Biotechnology is simply the combination of various microorganisms in order of making medicine through processing the microorganisms. The medicines are well examined so that they can at the end find a good treatment for cancer. The company is in association with other organization to achieve the goal of making a good antibody drug conjugate (ADC). This initiative gives hope to many patients suffering from cancer because they believe they will get good treatment. So far Adcetric is the very first drug that the firm has made and it has been taken to over 60 countries.

According to the financial graph of Seattle Genetics, the company has raised their bars financially therefore showing how much it has accomplished. The company has supplied more than 20 ADC s to clinical developments. Clay Siegall has highly contributed to these developments. $330 million is what the organization has so far achieved due to its commitment to work hard. The cancer victims have had so much hospitality from the firm and they are grateful.

Another medicine that the firm has created is SGN-CD33A. cancer types such as acute myeloid have been able to get this drug. So far the treatment has proved to be working, the patients and the company as well are glad about this outcome. Seattle Genetics aims to achieve better cancer therapies to help in the T. They have teamed up with a number of organizations that have the same expertise to make this a reality.